Leupin Nicolas
SEC insider (Form 3/4/5 filer). CIK 0002007766. Former Chief Medical Officer at NovoCure Ltd (NVCR). 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in WAYNE, PA.
Companies Leupin Nicolas has filed insider reports for
- NovoCure Ltd (NVCR): Officer, Former Chief Medical Officer
Leupin Nicolas
CIK: 0002007766
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (80.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVCR
NovoCure Ltd
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 4, 2026NVCR
NovoCure Ltd
SaleDirect1.1K shares at avg. $13.31$15K - Feb 27, 2026NVCR
NovoCure Ltd
SaleDirect1K shares at avg. $13.66$14K - Mar 4, 2025NVCR
NovoCure Ltd
AwardDirect55K shares at avg. $18.19$1000K - Feb 27, 2025NVCR
NovoCure Ltd
SaleDirect830 shares at avg. $19.92$17K - Feb 27, 2025NVCR
NovoCure Ltd
SaleDirect161 shares at avg. $20.55$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | NVCR NovoCure Ltd | Sale | 1,100 | $13.31 | $14,636 | Direct |
| Feb 27, 2026 | NVCR NovoCure Ltd | Sale | 1,029 | $13.66 | $14,060 | Direct |
| Mar 4, 2025 | NVCR NovoCure Ltd | Award | 54,975 | $18.19 | $999,995 | Direct |
| Feb 27, 2025 | NVCR NovoCure Ltd | Sale | 830 | $19.92 | $16,535 | Direct |
| Feb 27, 2025 | NVCR NovoCure Ltd | Sale | 161 | $20.55 | $3,308 | Direct |
1-5 of 5 transactions